LATEST UPDATES » Vol 23, No 07, July 2019 – Traditional Chinese medicine in modern healthcare — Integrating both worlds       » China approves norovirus vaccine for clinical trial       » AI offers breakthrough in cancer diagnosis       » Digital mental health strategy in China       » A wearable that's not to be laughed at       » Junk food could be responsible for the food allergy epidemic      
Gene-editing tool uses light to kill cancer cells
New technique can precisely alter or cut designated spot in genome

Chinese scientists recently designed a remote-controlled gene-editing platform using light, which can precisely target and kill cancer cells and offer revolutionary treatment for diseases including cancer, diabetes and Parkinson's disease.

A team led by Song Yujun, a professor at the College of Engineering and Applied Sciences at Nanjing University, designed the near-infrared (NIR) light-responsive nanocarrier for gene-editing tool CRISPR-Cas9 for cancer therapeutics, and the team published their findings in Science Advances.

"Using infrared light, the new technique can precisely alter or cut the designated spot in the genome, greatly improving the target effect of gene-editing tool," said Song. The strong penetration ability of infrared light provides possibilities for scientists to precisely control the gene editing tool, CRISPR-Cas9, in deep tissue.

The CRISPR-Cas9 technique allows genetic materials to be added, removed or altered at particular locations in the genome. But CRISPR-Cas9 is still a challenge to precision medicine worldwide due to its off-target effect and in some cases, may cause cancer in cells.

Off-target editing could result in serious consequences in cancer treatment, as it may cut or alter the wrong spot in the genome, thus killing healthy cells instead of cancerous ones.

In a notorious experiment that helped create the world's first gene-edited babies last year, He Jiankui, the scientist who conducted the experiment, used CRISPR-Cas9 to alter the CCR5 gene in twin baby girls. He was widely criticised as the technique cannot guarantee accurate excision of the gene.

The new technique developed by Song's team has been tested on mice with tumours, and the result found that the progression of tumours was gradually delayed on the mice that received the new technique for 20 days.

It was relatively easy to conduct the experiment on mice due to their small size, but the amount of light needed for humans is still uncertain.

China has tightened management on new biomedical technology after He's case, and a regulation on biomedical technology released in February states that high-risk clinical research projects including gene-editing technology must be approved by the health department of the State Council, and will have to pass both academic and ethics reviews.

Source: Global Times

Click here for the complete issue.

news Which country has the worst sleepers
news Asia is the fastest growing region for nutraceuticals
news 2018 Nobel Prize in Physiology or Medicine winners
news Vitafoods Asia expands by 40 per cent in 2018
Asia Pacific Biotech News

APBN Editorial Calendar 2019
Taiwan Medical tourism
Marijuana as medicine — Legal marijuana will open up scientific research
Driven by curiosity
Career developments for researchers
What's cracking — Antibodies in ostrich eggs
Clinical trials — What's in a name?
Traditional Chinese medicine in modern healthcare — Integrating both worlds
Editorial calendar is subjected to changes.
About Us
Available issues
Editorial Board
Letters to Editor
Instructions to Authors
Advertise with Us
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Deborah Seah
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
Copyright© 2019 World Scientific Publishing Co Pte Ltd  •  Privacy Policy